Standalone revenue grew 20.3%
Q2 standalone revenue was 4178 ₹ crore (Q2 FY26) versus 5026 ₹ crore (Q2 FY27). Standalone revenue grew 20.3%.
Watch: Separate new energy business
Home / Research / Exide Industries Limited
Standalone revenue grew 20.3%
https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=660daf15-6e1a-4ccd-8ee9-b4fef9285260.pdf
https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=660daf15-6e1a-4ccd-8ee9-b4fef9285260.pdf
https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=660daf15-6e1a-4ccd-8ee9-b4fef9285260.pdf
https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=660daf15-6e1a-4ccd-8ee9-b4fef9285260.pdf
Q2 standalone revenue was 4178 ₹ crore (Q2 FY26) versus 5026 ₹ crore (Q2 FY27). Standalone revenue grew 20.3%.
Watch: Separate new energy business
Q2 standalone EBITDA was 395 ₹ crore (Q2 FY26) versus 606 ₹ crore (Q2 FY27). EBITDA improved 53.6%.
Watch: Monitor cost of lead
Q2 EBITDA margin was 9.4 % (Q2 FY26) versus 12.1 % (Q2 FY27). Standalone EBITDA margin expanded 270 bps.
Watch: Check recurring gross margin
Q2 PBT was 298 ₹ crore (Q2 FY26) versus 522 ₹ crore (Q2 FY27). Profit before tax grew sharply.
Watch: Reconcile depreciation
Quarter ended September 2026 · Stance WATCH · issuer-sourced consolidated/standalone bases noted. Exide's core battery operation reported a stronger standalone Q2: revenue ₹5,026 crore compared with ₹4,178 crore, EBITDA ₹606 crore versus ₹395 crore, and PAT ₹386 crore versus ₹221 crore. The key portfolio question is whether lead-acid cash generation can fund a credible transition into lithium-ion cells without assuming the gigafactory has already earned mature returns. Standalone profitability is not consolidated new-energy project profitability. WATCH until cash requirements, customer qualification and ramp-up returns become clearer. [S1][S2]
| Key decision figure | Prior period | Current period |
|---|---|---|
| Q2 standalone revenue | 4178 ₹ crore (Q2 FY26) | 5026 ₹ crore (Q2 FY27) |
| Q2 standalone EBITDA | 395 ₹ crore (Q2 FY26) | 606 ₹ crore (Q2 FY27) |
| Q2 EBITDA margin | 9.4 % (Q2 FY26) | 12.1 % (Q2 FY27) |
| Q2 PBT | 298 ₹ crore (Q2 FY26) | 522 ₹ crore (Q2 FY27) |
| Q2 PAT | 221 ₹ crore (Q2 FY26) | 386 ₹ crore (Q2 FY27) |
| H1 revenue | 8688 ₹ crore (H1 FY26) | 10331 ₹ crore (H1 FY27) |
| H1 EBITDA | 943 ₹ crore (H1 FY26) | 1262 ₹ crore (H1 FY27) |
| H1 PBT | 727 ₹ crore (H1 FY26) | 1066 ₹ crore (H1 FY27) |
Six data-driven investor takeaways: Q2 standalone revenue: Standalone revenue grew 20.3%. Q2 standalone EBITDA: EBITDA improved 53.6%. Q2 EBITDA margin: Standalone EBITDA margin expanded 270 bps. Q2 PBT: Profit before tax grew sharply. Q2 PAT: PAT rose around 75%. H1 revenue: Six-month sales grew 18.9%. This original research text sits under the separate, sourced graphical Investment Briefing, and the source identifiers remain privately encoded in the report's provenance record.
Exide's core battery operation reported a stronger standalone Q2: revenue ₹5,026 crore compared with ₹4,178 crore, EBITDA ₹606 crore versus ₹395 crore, and PAT ₹386 crore versus ₹221 crore. The key portfolio question is whether lead-acid cash generation can fund a credible transition into lithium-ion cells without assuming the gigafactory has already earned mature returns. Standalone profitability is not consolidated new-energy project profitability. WATCH until cash requirements, customer qualification and ramp-up returns become clearer. [S1][S2]
Factual tests for the investment case
What this means for the next reporting period. Standalone revenue grew 20.3%. A substantive follow-up is to separate new energy business. EBITDA improved 53.6%. A substantive follow-up is to monitor cost of lead. Standalone EBITDA margin expanded 270 bps. A substantive follow-up is to check recurring gross margin. Management goals, future launches, announced capacity and unearned cash inflows are not booked as realized revenue or profit. The periods, currencies, reported and adjusted accounting labels must be held constant when recomputing growth.
The presentation's standalone results show Q2 revenue growing 20.3% YoY and EBITDA 53.6%, expanding EBITDA margin from 9.4% to 12.1%. PBT advanced from ₹298 crore to ₹522 crore, while standalone PAT grew from ₹221 crore to ₹386 crore. H1 sales reached ₹10,331 crore from ₹8,688 crore, H1 EBITDA increased from ₹943 crore to ₹1,262 crore and H1 PAT from ₹541 crore to ₹794 crore. These are the existing battery company's reported standalone measures; they do not necessarily include full economics of future lithium cell production. [S1][S2]
Factual tests for the investment case
What this means for the next reporting period. Standalone EBITDA margin expanded 270 bps. A substantive follow-up is to check recurring gross margin. Profit before tax grew sharply. A substantive follow-up is to reconcile depreciation. PAT rose around 75%. A substantive follow-up is to observe tax and cash. Management goals, future launches, announced capacity and unearned cash inflows are not booked as realized revenue or profit. The periods, currencies, reported and adjusted accounting labels must be held constant when recomputing growth.
Exide's installed brand and distribution network spans automotive OEM and replacement applications, telecom, industrial power, motive power and backup batteries. The company cited 120,000-plus customer touchpoints and more than 75 automotive OEM relationships, with major vertical integration into lead recycling. That channel depth helps price, warranty and repeat demand economics but can also expose working capital to lead prices and replacement cycles. Product localization and warranty claims are critical for assessing genuine margin quality. [S1][S2]
Factual tests for the investment case
What this means for the next reporting period. PAT rose around 75%. A substantive follow-up is to observe tax and cash. Six-month sales grew 18.9%. A substantive follow-up is to assess mix and volumes. H1 EBITDA increased 33.8%. A substantive follow-up is to test cost sustainability. Management goals, future launches, announced capacity and unearned cash inflows are not booked as realized revenue or profit. The periods, currencies, reported and adjusted accounting labels must be held constant when recomputing growth.
The company described the commissioning of its Exide Energy Solutions 6 GWh lithium-ion cell gigafactory in September 2026, alongside lithium packs/modules and cell-chemistry capabilities. Commissioning is a technical and commercial milestone, not proof of targeted production yield, full utilization or immediate cash recovery. Management highlighted OEM business in electric and conventional vehicles and new product launches; contracted customer qualification, offtake, manufacturing scrap and cell pricing should be monitored before adding new-energy profits into a base-case model. [S1][S2]
Factual tests for the investment case
What this means for the next reporting period. H1 EBITDA increased 33.8%. A substantive follow-up is to test cost sustainability. Half-year PBT grew ~46%. A substantive follow-up is to reconcile capex. H1 PAT grew ~47%. A substantive follow-up is to review dividend funding. Management goals, future launches, announced capacity and unearned cash inflows are not booked as realized revenue or profit. The periods, currencies, reported and adjusted accounting labels must be held constant when recomputing growth.
Exide's snapshot describes a zero-debt balance sheet and long-running cash generation in its mature businesses, but the gigafactory investment changes expected capital intensity and financing needs. Cell manufacturing carries depreciation, equipment obsolescence, raw-material sourcing and qualification costs; the timing of internal cash transfers to the subsidiary matters.
Q2 standalone EBITDA ₹606 crore cannot be treated as free cash available for dividends or new plants without the actual consolidated cash-flow statement and approved capex commitments. The presentation's zero-debt description should be read as presented, not extrapolated to all future reporting periods. [S1][S2]
Factual tests for the investment case
What this means for the next reporting period. H1 PAT grew ~47%. A substantive follow-up is to review dividend funding. H1 margin improved 130 bps. A substantive follow-up is to test replacement demand. PBT margin increased 330 bps. A substantive follow-up is to separate finance effects. Management goals, future launches, announced capacity and unearned cash inflows are not booked as realized revenue or profit. The periods, currencies, reported and adjusted accounting labels must be held constant when recomputing growth.
An upside case involves battery demand growth across auto, replacement and industrial sectors, stable pricing/lead costs and qualified customer uptake from the cell facility at acceptable yields. Base conditions have good standalone cash earnings while lithium commercialization produces delayed returns and upfront depreciation. Downside risks include lead-price inflation, warranty failures, cell oversupply, technology change or substantially lower gigafactory utilization. Future capacity should be assessed as a risk-bearing investment, not current earnings automatically capitalized. [S1][S2]
Factual tests for the investment case
What this means for the next reporting period. Standalone revenue grew 20.3%. A substantive follow-up is to separate new energy business. EBITDA improved 53.6%. A substantive follow-up is to monitor cost of lead. Standalone EBITDA margin expanded 270 bps. A substantive follow-up is to check recurring gross margin. Management goals, future launches, announced capacity and unearned cash inflows are not booked as realized revenue or profit. The periods, currencies, reported and adjusted accounting labels must be held constant when recomputing growth.
WATCH standalone quarterly revenue ₹5,026 crore, EBITDA ₹606 crore and PAT ₹386 crore, with Q2 FY26 comparisons; monitor H1 revenue ₹10,331 crore and EBITDA ₹1,262 crore. Separately track cell plant utilization against the 6 GWh announced capacity, OEM qualifications, recycling economics and net capital support to the new-energy business. Upgrade only when incremental plant returns and cash conversion support current price; downgrade if capex requirements overwhelm legacy profits or cell pricing weakens. [S1][S2]
Factual tests for the investment case
What this means for the next reporting period. Standalone EBITDA margin expanded 270 bps. A substantive follow-up is to check recurring gross margin. Profit before tax grew sharply. A substantive follow-up is to reconcile depreciation. PAT rose around 75%. A substantive follow-up is to observe tax and cash. Management goals, future launches, announced capacity and unearned cash inflows are not booked as realized revenue or profit. The periods, currencies, reported and adjusted accounting labels must be held constant when recomputing growth.
[S1] Exide Industries Limited Q2 FY27 earnings-call transcript — accepted transcript covering management and investor questions about the September quarter. [S2] Exide Industries Limited Q2 and H1 FY27 investor presentation — financial statements and management operating metrics.
Evidence limitations: Company filings are the research source. Specific valuation multiples, market price, future dividends, share counts or debt forecasts are omitted when not supported by these documents. Management guidance and the issuer's adjusted figures must not be mistaken for statutory earnings, or for independently certified cash flow.
https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=660daf15-6e1a-4ccd-8ee9-b4fef9285260.pdf
https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=660daf15-6e1a-4ccd-8ee9-b4fef9285260.pdf
https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=660daf15-6e1a-4ccd-8ee9-b4fef9285260.pdf
https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=660daf15-6e1a-4ccd-8ee9-b4fef9285260.pdf
This is dated research, not a live market quote. Scenarios and historical performance are not guarantees.